Similar Articles
491 Patients with hepatocellular carcinoma that die during the first year of liver transplantation have high blood sFasL concentrations
492 Possible mechanisms associated with immune escape and apoptosis on anti-hepatocellular carcinoma effect of Mu Ji Fang granules
493 Systemic treatment for unresectable hepatocellular carcinoma
494 Clinical outcomes of lenvatinib plus transarterial chemoembolization with or without programmed death receptor-1 inhibitors in unresectable hepatocellular carcinoma
495 Predictors of early and late hepatocellular carcinoma recurrence
496 Better performance of PIVKA-II for detecting hepatocellular carcinoma in patients with chronic liver disease with normal total bilirubin
497 Network meta-analysis of the prognosis of curative treatment strategies for recurrent hepatocellular carcinoma after hepatectomy
498 Does size matter for resection of giant versus non-giant hepatocellular carcinoma? A meta-analysis
499 Current status and prospect of treatments for recurrent hepatocellular carcinoma
500 Type 2 diabetes mellitus characteristics affect hepatocellular carcinoma development in chronic hepatitis B patients with cirrhosis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA